For instance, in mouse xenograft models of human glioma, high POSTN mediated enhanced expression of TGFB1 and HIF1 alpha, which resulted in acquired resistance to anti-VEGF-A therapy.37 This evidence concerns the gene TGFB1 and central nervous system cancer.